University Hospitals of Leicester, Leicester, UK.
Ann N Y Acad Sci. 2010 Sep;1205:262-7. doi: 10.1111/j.1749-6632.2010.05678.x.
The increased interest in phytoestrogens in the management of menopausal symptoms followed the publication of the Women's Health Initiative study. A wide-spread perception that these plant-derived compounds are equivalent to estrogen was established. These compounds evolved to fulfill the needs of plant physiological processes and are natural for the plant cells but not natural to the human cell. Epidemiological data suggest a possible protective effect of phytoestrogen if consumed during adolescence, but later on in life this effect is not clear. The utility of phytoestrogen as a "natural and safe" alternative to estrogen in alleviating vasomotor symptoms has failed the test in randomized clinical trials. Because many breast cancer sufferers seek in phytoestrogen a relief of estrogen deficiency symptoms, the possible interaction of such remedies with risk of recurrence of breast cancer or interference with tamoxifen action should not be overlooked.
植物雌激素在绝经症状管理中的应用日益受到关注,这是继妇女健康倡议研究之后的结果。人们普遍认为这些植物衍生的化合物等同于雌激素。这些化合物是为了满足植物生理过程的需要而进化而来的,对植物细胞来说是天然的,但对人体细胞来说并非如此。流行病学数据表明,青春期摄入植物雌激素可能具有保护作用,但在生命后期,这种作用尚不清楚。在随机临床试验中,植物雌激素作为缓解血管舒缩症状的“天然和安全”雌激素替代物的效用未能通过测试。由于许多乳腺癌患者寻求植物雌激素来缓解雌激素缺乏症状,因此不应忽视这些补救措施与乳腺癌复发风险或与他莫昔芬作用干扰的可能相互作用。